Cargando…

Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study

INTRODUCTION: Idiosyncratic drug reactions (IDRs) are unexpected responses to a drug. The spectrums of severe cutaneous reactions include Stevens–Johnson Syndrome (SJS), SJS/Lyell Syndrome and Toxic Epidermal Necrolysis (TEN). The conditions are associated with high mortality. This study was designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadeyibi, I. O., Ademiluyi, S. A., Ajose, F. O., Jewo, P. I., Akinola, O. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263276/
https://www.ncbi.nlm.nih.gov/pubmed/22279281
http://dx.doi.org/10.4103/0970-0358.90824
_version_ 1782221847078633472
author Fadeyibi, I. O.
Ademiluyi, S. A.
Ajose, F. O.
Jewo, P. I.
Akinola, O. I.
author_facet Fadeyibi, I. O.
Ademiluyi, S. A.
Ajose, F. O.
Jewo, P. I.
Akinola, O. I.
author_sort Fadeyibi, I. O.
collection PubMed
description INTRODUCTION: Idiosyncratic drug reactions (IDRs) are unexpected responses to a drug. The spectrums of severe cutaneous reactions include Stevens–Johnson Syndrome (SJS), SJS/Lyell Syndrome and Toxic Epidermal Necrolysis (TEN). The conditions are associated with high mortality. This study was designed to determine the causal agents, patterns of presentations, review the management and make recommendations to reduce the incidence and mortality of this class of drug reactions. MATERIALS AND METHODS: A retrospective study was made of patients seen with IDR in the Lagos State University Teaching Hospital, LASUTH, between January, 2004 and December, 2008. They were cases admitted with bullous skin eruptions with associated systemic symptoms. RESULTS: Sixty-seven patients were seen, with 45 (67.2%) satisfying the inclusion criteria. Fifteen males and 30 females were involved, giving a male to female (M:F) ratio of 1:2. Their ages ranged from 7 to 79 years (mean, 40.02 ± 17.89 years). Peak incidences occurred among the 20–24 and 30–34 year age groups. The causal agents were antibiotics (48.89%), sulphonamides (24.44%), herbal preparations (17.78%) and artemisinin drugs (8.89%). CONCLUSIONS: The age groups with the peak incidence are the most likely to indulge more in drug abuse in environments with poor drug control. Diagnosis of SJS, SJS/TEN and TEN were missed in many patients at first contact due to the progressive nature of the conditions. Patients needed reviews at regular intervals when IDR was suspected. Health education to prevent drug abuse is important and herbal preparations should be scientifically studied to determine the efficacy and side-effects.
format Online
Article
Text
id pubmed-3263276
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32632762012-01-25 Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study Fadeyibi, I. O. Ademiluyi, S. A. Ajose, F. O. Jewo, P. I. Akinola, O. I. Indian J Plast Surg Original Article INTRODUCTION: Idiosyncratic drug reactions (IDRs) are unexpected responses to a drug. The spectrums of severe cutaneous reactions include Stevens–Johnson Syndrome (SJS), SJS/Lyell Syndrome and Toxic Epidermal Necrolysis (TEN). The conditions are associated with high mortality. This study was designed to determine the causal agents, patterns of presentations, review the management and make recommendations to reduce the incidence and mortality of this class of drug reactions. MATERIALS AND METHODS: A retrospective study was made of patients seen with IDR in the Lagos State University Teaching Hospital, LASUTH, between January, 2004 and December, 2008. They were cases admitted with bullous skin eruptions with associated systemic symptoms. RESULTS: Sixty-seven patients were seen, with 45 (67.2%) satisfying the inclusion criteria. Fifteen males and 30 females were involved, giving a male to female (M:F) ratio of 1:2. Their ages ranged from 7 to 79 years (mean, 40.02 ± 17.89 years). Peak incidences occurred among the 20–24 and 30–34 year age groups. The causal agents were antibiotics (48.89%), sulphonamides (24.44%), herbal preparations (17.78%) and artemisinin drugs (8.89%). CONCLUSIONS: The age groups with the peak incidence are the most likely to indulge more in drug abuse in environments with poor drug control. Diagnosis of SJS, SJS/TEN and TEN were missed in many patients at first contact due to the progressive nature of the conditions. Patients needed reviews at regular intervals when IDR was suspected. Health education to prevent drug abuse is important and herbal preparations should be scientifically studied to determine the efficacy and side-effects. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3263276/ /pubmed/22279281 http://dx.doi.org/10.4103/0970-0358.90824 Text en Copyright: © Indian Journal of Plastic Surgery http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Fadeyibi, I. O.
Ademiluyi, S. A.
Ajose, F. O.
Jewo, P. I.
Akinola, O. I.
Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
title Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
title_full Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
title_fullStr Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
title_full_unstemmed Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
title_short Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study
title_sort severe idiosyncratic drug reactions with epidermal necrolysis: a 5-year study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263276/
https://www.ncbi.nlm.nih.gov/pubmed/22279281
http://dx.doi.org/10.4103/0970-0358.90824
work_keys_str_mv AT fadeyibiio severeidiosyncraticdrugreactionswithepidermalnecrolysisa5yearstudy
AT ademiluyisa severeidiosyncraticdrugreactionswithepidermalnecrolysisa5yearstudy
AT ajosefo severeidiosyncraticdrugreactionswithepidermalnecrolysisa5yearstudy
AT jewopi severeidiosyncraticdrugreactionswithepidermalnecrolysisa5yearstudy
AT akinolaoi severeidiosyncraticdrugreactionswithepidermalnecrolysisa5yearstudy